BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19344646)

  • 1. Accumulation of labile zinc in neurons and astrocytes in the spinal cords of G93A SOD-1 transgenic mice.
    Kim J; Kim TY; Hwang JJ; Lee JY; Shin JH; Gwag BJ; Koh JY
    Neurobiol Dis; 2009 May; 34(2):221-9. PubMed ID: 19344646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
    Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
    Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1(G93A) transgenic mice.
    Kobayakawa Y; Sakumi K; Kajitani K; Kadoya T; Horie H; Kira J; Nakabeppu Y
    Neuropathol Appl Neurobiol; 2015 Feb; 41(2):227-44. PubMed ID: 24707896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis.
    Pehar M; Cassina P; Vargas MR; Castellanos R; Viera L; Beckman JS; Estévez AG; Barbeito L
    J Neurochem; 2004 Apr; 89(2):464-73. PubMed ID: 15056289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of intracellular copper homeostasis is common to transgenic mice expressing human mutant superoxide dismutase-1s regardless of their copper-binding abilities.
    Tokuda E; Okawa E; Watanabe S; Ono S; Marklund SL
    Neurobiol Dis; 2013 Jun; 54():308-19. PubMed ID: 23321002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-bound crotonaldehyde accumulates in the spinal cord of superoxide dismutase-1 mutation-associated familial amyotrophic lateral sclerosis and its transgenic mouse model.
    Shibata N; Kawaguchi M; Uchida K; Kakita A; Takahashi H; Nakano R; Fujimura H; Sakoda S; Ihara Y; Nobukuni K; Takehisa Y; Kuroda S; Kokubo Y; Kuzuhara S; Honma T; Mochizuki Y; Mizutani T; Yamada S; Toi S; Sasaki S; Iwata M; Hirano A; Yamamoto T; Kato Y; Sawada T; Kobayashi M
    Neuropathology; 2007 Feb; 27(1):49-61. PubMed ID: 17319283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis.
    Brambilla L; Guidotti G; Martorana F; Iyer AM; Aronica E; Valori CF; Rossi D
    Hum Mol Genet; 2016 Jul; 25(14):3080-3095. PubMed ID: 27288458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parvalbumin and calbindin D-28k immunoreactivity in transgenic mice with a G93A mutant SOD1 gene.
    Sasaki S; Warita H; Komori T; Murakami T; Abe K; Iwata M
    Brain Res; 2006 Apr; 1083(1):196-203. PubMed ID: 16546142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
    Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L
    Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model.
    Cai M; Lee KW; Choi SM; Yang EJ
    Neurol Res; 2015 Mar; 37(3):253-62. PubMed ID: 25213598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
    Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
    Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis.
    Liang X; Wang Q; Shi J; Lokteva L; Breyer RM; Montine TJ; Andreasson K
    Ann Neurol; 2008 Sep; 64(3):304-14. PubMed ID: 18825663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo.
    Chi L; Ke Y; Luo C; Gozal D; Liu R
    Neuroscience; 2007 Feb; 144(3):991-1003. PubMed ID: 17150307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive loss of a glial potassium channel (KCNJ10) in the spinal cord of the SOD1 (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
    Kaiser M; Maletzki I; Hülsmann S; Holtmann B; Schulz-Schaeffer W; Kirchhoff F; Bähr M; Neusch C
    J Neurochem; 2006 Nov; 99(3):900-12. PubMed ID: 16925593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS.
    Kadoyama K; Funakoshi H; Ohya W; Nakamura T
    Neurosci Res; 2007 Dec; 59(4):446-56. PubMed ID: 17935811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS.
    Barbeito AG; Martinez-Palma L; Vargas MR; Pehar M; Mañay N; Beckman JS; Barbeito L; Cassina P
    Neurobiol Dis; 2010 Mar; 37(3):574-80. PubMed ID: 19914377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamine synthetase activity and expression are not affected by the development of motor neuronopathy in the G93A SOD-1/ALS mouse.
    Fray AE; Dempster S; Williams RE; Cookson MR; Shaw PJ
    Brain Res Mol Brain Res; 2001 Oct; 94(1-2):131-6. PubMed ID: 11597773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients.
    Johann S; Heitzer M; Kanagaratnam M; Goswami A; Rizo T; Weis J; Troost D; Beyer C
    Glia; 2015 Dec; 63(12):2260-73. PubMed ID: 26200799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.